Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Holmes

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
The New Zealand Medical Journal|October 14, 1981
Vitamilk 20M B Holmes
The Journal of Invasive Cardiology|April 4, 2000
Optimizing antiplatelet therapy in patients with acute coronary syndromes: a role for monitoring platelet reactivityM B Holmes, D J Schneider
The American Journal of Cardiology|July 30, 1999
Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjectsM B Holmes, B E Sobel, D J Schneider
The New England Journal of Medicine|August 28, 1980
Acquisition of typhoid fever from proficiency-testing specimensM B Holmes, D L Johnson, N J Fiumara, et al.
The American Journal of Cardiology|March 23, 2000
Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial InfarctionM B Holmes, B E Sobel, C P Cannon, et al.
Thrombosis Research|July 27, 1999
Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implicationsM B Holmes, B E Sobel, D B Howard, et al.
Circulation|March 1, 2000
Images in cardiovascular medicine. Abciximab-associated pseudothrombocytopeniaM B Holmes, S Kabbani, M W Watkins, et al.
Circulation|October 25, 2000
Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapyM B Holmes, D J Schneider, M G Hayes, et al.
Thrombosis and Haemostasis|March 15, 2001
Time and dose dependent augmentation of inhibitory effects of abciximab by aspirinD J Schneider, P Q Baumann, M B Holmes, et al.
Coronary Artery Disease|May 16, 2001
Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximabM B Holmes, S S Kabbani, C M Terrien, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
The New Zealand Medical Journal|October 14, 1981
Vitamilk 20M B Holmes
The Journal of Invasive Cardiology|April 4, 2000
Optimizing antiplatelet therapy in patients with acute coronary syndromes: a role for monitoring platelet reactivityM B Holmes, D J Schneider
The American Journal of Cardiology|July 30, 1999
Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjectsM B Holmes, B E Sobel, D J Schneider
The New England Journal of Medicine|August 28, 1980
Acquisition of typhoid fever from proficiency-testing specimensM B Holmes, D L Johnson, N J Fiumara, et al.
The American Journal of Cardiology|March 23, 2000
Increased platelet reactivity in patients given orbofiban after an acute coronary syndrome: an OPUS-TIMI 16 substudy. Orbofiban in Patients with Unstable coronary syndromes. Thrombolysis In Myocardial InfarctionM B Holmes, B E Sobel, C P Cannon, et al.
Thrombosis Research|July 27, 1999
Differences between activation thresholds for platelet P-selectin glycoprotein IIb-IIIa expression and their clinical implicationsM B Holmes, B E Sobel, D B Howard, et al.
Circulation|March 1, 2000
Images in cardiovascular medicine. Abciximab-associated pseudothrombocytopeniaM B Holmes, S Kabbani, M W Watkins, et al.
Circulation|October 25, 2000
Novel, bedside, tissue factor-dependent clotting assay permits improved assessment of combination antithrombotic and antiplatelet therapyM B Holmes, D J Schneider, M G Hayes, et al.
Thrombosis and Haemostasis|March 15, 2001
Time and dose dependent augmentation of inhibitory effects of abciximab by aspirinD J Schneider, P Q Baumann, M B Holmes, et al.
Coronary Artery Disease|May 16, 2001
Quantification by flow cytometry of the efficacy of and interindividual variation of platelet inhibition induced by treatment with tirofiban and abciximabM B Holmes, S S Kabbani, C M Terrien, et al.
Pageof 2